Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic diseases
Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic…
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
Lucid Diligence Brief: Lumonus A$25M Series B
Lucid Diligence Brief: Lumonus A$25M Series B Professional audiences only. Not…
Lucid Diligence Brief: Amae Health $25M Series B
Lucid Diligence Brief: Amae Health $25M Series B Professional audiences only.…
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A Professional…
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing…
Lucid Diligence Brief: NEOK Bio $75M Series A
Lucid Diligence Brief: NEOK Bio $75M Series A Professional audiences only. Not…
Lucid Diligence Brief: AAVantgarde Bio $141M Series B
Lucid Diligence Brief: AAVantgarde Bio $141M Series B Professional audiences…
Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration
Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration…
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka…
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health Professional…
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…